Clinical Trial Update: Improved Diagnosis of Ovarian Cancer by Use of Circulating Tumor DNA as a Biomarker

View source ↗

Summary

This ongoing clinical trial investigates the use of circulating tumor DNA as a biomarker to improve the diagnosis of ovarian cancer and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer
• Ovarian Cysts

Snippet

Sponsor: University of Aarhus | Conditions: Ovarian Neoplasms, Ovary Cancer | Status: RECRUITING